Accordingly, DNAM-1-deficient mice showed increased tumor development and mortality after transplantation with tumors that express PVR, due to a reduction in the ability of NK and cytotoxic T cells to recognize and kill tumor cells [75]. The gene discussed is CD226; the disease is neoplasm.